STAGE IIIA NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Tough-to-Treat cancers
Disease control OngoingThis early-phase study tested a new drug called sEphB4-HSA combined with standard chemotherapy in 61 people with advanced or metastatic solid tumors (like head and neck, pancreatic, lung, and gallbladder cancers). The goal was to find the best dose and check for side effects. Res…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 01, 2026 18:27 UTC
-
New hope: targeted pill before surgery for lung cancer patients
Disease control OngoingThis study tests whether the drug osimertinib, taken before surgery, can shrink tumors in people with early-stage non-small cell lung cancer that has a specific gene mutation (EGFR). About 27 adults with stage I to IIIA disease will receive the drug before their operation. The ma…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC